16–18 September 2026 • Events

Atlantic Biomedical at WHX Nairobi 2026: Expanding Access to Advanced Dialysis Solutions in Africa

Atlantic Biomedical proudly participated in WHX Nairobi 2026, held from 16–18 September 2026 at Kenyatta International Convention Centre (KICC), Nairobi, Kenya, strengthening its presence in the African healthcare market and connecting with healthcare professionals, distributors, dialysis service providers, and industry partners from across the region.

With nearly four decades of experience in the haemodialysis industry, Atlantic Biomedical showcased its range of EU CE Certified (CE 0123) haemodialysis consumables and dialysis solutions, with a focus on quality, reliability, ease of use, and efficient dialysis operations. The products are certified under the European Union regulatory framework, with certification by TÜV SÜD, Munich, Germany.

Showcasing Advanced Haemodialysis Solutions

At WHX Nairobi 2026, Atlantic Biomedical presented its portfolio of dialysis products designed to support modern haemodialysis centres and healthcare providers.

Key products showcased included:

• Renacart – Pre-filled bicarbonate cartridges designed to simplify bicarbonate delivery during dialysis while reducing manual handling, preparation, and storage requirements.
• Renabag – Bicarbonate bags available in different capacities, providing a convenient bicarbonate solution for efficient dialysis operations.
• Dry Citracon – A dry acid concentrate solution designed for haemodialysis applications, offering convenient handling, transportation, and storage.
• Renasonl – Concentrated haemodialysis solution available in different pack sizes and configurations to meet diverse dialysis requirements.
• Renaclean Plus – A reprocessing machine designed for dialyzer reprocessing applications, supporting efficient and consistent reprocessing workflows.
• Renaclean & Renasteril Hot – Solutions designed to support dialysis equipment and dialyzer reprocessing requirements.

The exhibition provided an excellent opportunity for visitors to learn more about the applications, specifications and benefits of Atlantic Biomedical's products and to explore potential opportunities for collaboration.

Building Connections Across Africa

WHX Nairobi 2026 provided Atlantic Biomedical with an important platform to engage with healthcare organizations, distributors, dialysis service providers, and potential partners from Kenya and other African markets.

During the exhibition, the Atlantic Biomedical team held productive discussions on:

• Distribution and partnership opportunities
• Product registration and regulatory requirements
• Haemodialysis consumables
• Bicarbonate cartridge and bicarbonate bag requirements
• Dry acid concentrate solutions
• Product evaluation and sampling
• Customized formulations for specific market requirements

These discussions provided valuable insights into the evolving requirements of dialysis providers across African markets and opened opportunities for potential long-term partnerships.

Supporting the Growing Dialysis Market

The need for reliable, consistent and cost-effective dialysis solutions continues to grow across emerging healthcare markets.

Atlantic Biomedical is committed to supporting healthcare providers by offering dialysis products that combine quality, consistency, convenience and practical solutions for modern haemodialysis centres.

Through its international experience and expanding global network, Atlantic Biomedical continues to work with healthcare partners to make its haemodialysis solutions accessible to healthcare providers in an increasing number of markets.

Strengthening Atlantic Biomedical's Global Presence

Participation in WHX Nairobi 2026 represents another important milestone in Atlantic Biomedical's international expansion and its continued engagement with the African healthcare market.

With a history spanning nearly 40 years in the haemodialysis consumables industry, Atlantic Biomedical has built extensive experience serving healthcare markets in India and internationally.

The company's international presence includes markets such as:

Mauritius | Iran | Saudi Arabia | Oman | Ethiopia | Kenya | Nigeria | Egypt | South Africa | Argentina

Through its international partnerships and growing export network, Atlantic Biomedical continues to explore opportunities to introduce its haemodialysis solutions to additional healthcare markets.

WHX Nairobi provided Atlantic Biomedical with an opportunity to strengthen existing relationships, establish new connections, understand market requirements, and explore potential collaborations across Africa.

Looking Ahead

Atlantic Biomedical extends its sincere appreciation to everyone who visited our booth and took the time to meet with our team during WHX Nairobi 2026.

The conversations, insights, and connections made during the exhibition have created opportunities for collaboration, product evaluation, distribution partnerships, and market development.

Atlantic Biomedical looks forward to building on these relationships and continuing its journey of delivering reliable haemodialysis solutions to healthcare providers across Africa and around the world.